Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2016

Jul 19, 2016

32337_dirs_2016-07-19_0d5ba32f-34a4-4b1e-bf34-d9afc7c09398.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2016-07-15

Reporting Person: Friedman Mark J (General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-07-15 Common Stock M 10008 $59.98 Acquired 10208 Direct
2016-07-15 Common Stock M 10603 $30.44 Acquired 20811 Direct
2016-07-15 Common Stock D 14147 $65.25 Disposed 6664 Direct
2016-07-15 Common Stock F 2748 $65.25 Disposed 3916 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-07-15 Stock Appreciation Rights $59.98 M 10008 Disposed 2024-04-30 Common Stock (10008) Direct
2016-07-15 Stock Appreciation Rights $30.44 M 10603 Disposed 2025-03-02 Common Stock (10603) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2015.

F2: The reporting person received an aggregate of 20,611 shares of common stock upon the net exercise of the stock appreciation rights ("SARS"). The reporting person forfeited an aggregate of 14,147 shares of common stock underlying the SARS in payment of the exercise price and an aggregate of 2,748 shares of common stock underlying the SARS to satisfy the aggregate withholding tax obligation resulting from the exercise, using the closing stock price on July 15, 2016 of $65.25.